Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012 (Q33570297)

28 July 2017

title

Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012 (English)

1 reference

differentiated thyroid carcinoma

28 July 2017

main subject

1 reference

Steven I Sherman

16

0 references

Jacqueline Jonklaas

4

object named as

Jacqueline Jonklaas

1 reference

28 July 2017

Aubrey A Carhill

1

1 reference

28 July 2017

Danielle R Litofsky

2

1 reference

28 July 2017

Douglas S Ross

3

1 reference

28 July 2017

David S Cooper

5

1 reference

28 July 2017

James D Brierley

6

1 reference

28 July 2017

Paul W Ladenson

7

1 reference

28 July 2017

Kenneth B Ain

8

1 reference

28 July 2017

Henry G Fein

9

1 reference

28 July 2017

Bryan R Haugen

10

1 reference

28 July 2017

James Magner

11

1 reference

28 July 2017

Monica C Skarulis

12

1 reference

28 July 2017

David L Steward

13

1 reference

28 July 2017

Mingxhao Xing

14

1 reference

28 July 2017

Harry R Maxon

15

1 reference

28 July 2017

language of work or name

English

0 references

publication date

14 July 2015

1 reference

The Journal of Clinical Endocrinology and Metabolism

28 July 2017

published in

1 reference

28 July 2017

volume

100

1 reference

28 July 2017

issue

9

1 reference

28 July 2017

page(s)

3270-3279

1 reference

Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Disease severity and radioactive iodine use for thyroid cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

The impact of age and gender on papillary thyroid cancer survival.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

International patterns and trends in thyroid cancer incidence, 1973-2002

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Risk for fracture in women with low serum levels of thyroid-stimulating hormone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Estimating causal effects from large data sets using propensity scores

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Quality of life in cured patients with differentiated thyroid carcinoma.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Thyroid hormone use, hyperthyroidism and mortality in older women

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5393522

Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial

31 October 2018

1 reference

12 December 2020

Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry

1 reference

12 December 2020

1 reference

12 December 2020

Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine

1 reference

12 December 2020

Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation stu

1 reference

12 December 2020

Subclinical thyroid disease

1 reference

12 December 2020

Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group

1 reference

12 December 2020

Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas

1 reference

12 December 2020

Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006

1 reference

12 December 2020

Outcomes of patients with differentiated thyroid carcinoma following initial therapy

1 reference

12 December 2020

Recurrence after treatment of micropapillary thyroid cancer

1 reference

12 December 2020

Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma

1 reference

12 December 2020

Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine

1 reference

12 December 2020

Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring

1 reference

12 December 2020

Identifiers

DOI

10.1210/JC.2015-1346

1 reference

28 July 2017

1 reference

28 July 2017

1 reference